Cannell Capital - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 64 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 1.1%.

Quarter-by-quarter ownership
Cannell Capital ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2023$30,976
-3.2%
16,8350.0%0.01%0.0%
Q4 2022$31,987
-11.1%
16,8350.0%0.01%
-25.0%
Q3 2022$36,000
+227.3%
16,835
+320.8%
0.01%
+300.0%
Q2 2022$11,0004,0010.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$38,130,00036.42%
FRAZIER MANAGEMENT LLC 3,746,857$19,446,0001.50%
TFG Asset Management GP Ltd 2,700,000$14,013,0000.84%
Nantahala Capital Management 4,077,509$21,162,0000.74%
Ikarian Capital, LLC 544,819$2,827,0000.42%
HARBOR CAPITAL ADVISORS, INC. 211,319$1,097,0000.40%
Blackstone Inc. 17,985,611$93,345,0000.23%
Resolute Capital Asset Partners LLC 65,115$338,0000.22%
MYDA Advisors LLC 125,000$649,0000.17%
Eversept Partners, LP 401,540$2,083,9930.13%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders